Xvivo Perfusion Current Valuation vs. Return On Asset
| XVIPF Stock | USD 41.23 0.77 1.83% |
For Xvivo Perfusion profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Xvivo Perfusion to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Xvivo Perfusion AB utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Xvivo Perfusion's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Xvivo Perfusion AB over time as well as its relative position and ranking within its peers.
Xvivo |
Xvivo Perfusion AB Return On Asset vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Xvivo Perfusion's current stock value. Our valuation model uses many indicators to compare Xvivo Perfusion value to that of its competitors to determine the firm's financial worth. Xvivo Perfusion AB is rated first in current valuation category among its peers. It is rated first in return on asset category among its peers . The ratio of Current Valuation to Return On Asset for Xvivo Perfusion AB is about 94,052,969,649 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Xvivo Perfusion's earnings, one of the primary drivers of an investment's value.Xvivo Current Valuation vs. Competition
Xvivo Perfusion AB is rated first in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Medical Devices industry is at this time estimated at about 539.09 Million. Xvivo Perfusion totals roughly 536.1 Million in current valuation claiming about 99% of all equities under Medical Devices industry.
Xvivo Return On Asset vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Xvivo Perfusion |
| = | 536.1 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Xvivo Perfusion |
| = | 0.0057 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Xvivo Return On Asset Comparison
Xvivo Perfusion is currently under evaluation in return on asset category among its peers.
Xvivo Perfusion Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Xvivo Perfusion, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Xvivo Perfusion will eventually generate negative long term returns. The profitability progress is the general direction of Xvivo Perfusion's change in net profit over the period of time. It can combine multiple indicators of Xvivo Perfusion, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Xvivo Perfusion AB , a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden. Xvivo Perfusion operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 115 people.
Xvivo Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Xvivo Perfusion. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Xvivo Perfusion position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Xvivo Perfusion's important profitability drivers and their relationship over time.
Use Xvivo Perfusion in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Xvivo Perfusion position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xvivo Perfusion will appreciate offsetting losses from the drop in the long position's value.Xvivo Perfusion Pair Trading
Xvivo Perfusion AB Pair Trading Analysis
The ability to find closely correlated positions to Xvivo Perfusion could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Xvivo Perfusion when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Xvivo Perfusion - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Xvivo Perfusion AB to buy it.
The correlation of Xvivo Perfusion is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Xvivo Perfusion moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Xvivo Perfusion AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Xvivo Perfusion can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Xvivo Perfusion position
In addition to having Xvivo Perfusion in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Commodities Funds Thematic Idea Now
Commodities Funds
Funds or Etfs investing in commodities such as oil, gold, corn, soy, and agricultural goods. The Commodities Funds theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Commodities Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Xvivo Pink Sheet
To fully project Xvivo Perfusion's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Xvivo Perfusion AB at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Xvivo Perfusion's income statement, its balance sheet, and the statement of cash flows.